Project: AMR Dx Global

Acronym	AMR Dx Global (Reference Number: JPIAMR_2018_N021)
Duration	01/01/2019 - 31/10/2020
Project Topic	AMR Dx Global is a transnational, multi-sectorial, multi-stakeholder and interdisciplinary network focussed on rapid diagnostics training and capacity building to tackle the global threat of antimicrobial resistance with a One Health approach. The network is coordinated by the University of Edinburg and brings together partners from 18 countries including international organisations like WHO, FIND, AMREF and ICAN. AMR Dx Global will develop a Strategic Action Plan on training to support the formation of the JPIAMR-VRI and focus on Diagnostics as one of the six priority topics of the JPIAMR Strategic Research Agenda. AMR Dx Global evolved from the successful JPIAMR Working Group AMR-RDT, which identified barriers to development, implementation and use of rapid diagnostics to tackle AMR. The findings of AMR-RDT has been published in Nature Reviews Microbiology and Lancet Infectious Diseases for publication. As before, AMR Dx Global has assembled an outstanding group of experts selected to match the scope of the JPIAMR VRI. The new network provides exceptional access to and input from the leading national and international institutions, networks and activities in the field, which amplifies its immediate reach. Most importantly, the extensive coverage of existing global, international and national initiatives relevant to AMR, diagnostics, training, teaching and capacity building constitutes an exceptional opportunity for JPIAMR-VRI to receive input to its strategy and mitigate the risk of duplication amongst the many emerging transnational initiatives on AMR. AMR Dx Global will run a twelve-month programme including two major meetings and structured data collection on existing strategies, needs and gaps in AMR diagnostics training and capacity building to develop the Strategic Action Plan on training for Diagnostics. The framework for AMR Dx Global and its ultimate vision is the set-up of a JPIAMR Virtual School of Diagnostics as part of the JPIAMR-VRI. Such Virtual School would create world-leading opportunity to connect the global AMR diagnostics community and stakeholders with the next generation of AMR scientists and turn the challenge of AMR into an opportunity for the next generation of researchers and the sustainable development goals.
Website	visit project website
Network	JPI AMR
Call	8th Joint Call of JPIAMR

Project partner

Number	Name	Role	Country
1	University of Edinburgh	Coordinator	United Kingdom
2	BioMérieux	Observer	France
3	University of the Arts London	Observer	United Kingdom
4	KTH Royal Institute of Technology	Observer	Sweden
5	Cairo University	Observer	Egypt
6	Foundation for Innovative New Diagnostics	Observer	Switzerland
7	Longitude Prize, Nesta	Observer	United Kingdom
8	University of Tübingen	Observer	Germany
9	World Health Organization (WHO)	Observer	Switzerland
10	Fraunhofer Institute for Cell Therapy and Immunology	Observer	Germany
11	Curetis GmbH	Observer	Germany
12	Robert Koch Institute	Observer	Germany
13	University Hospital of North Norway and Arctic University of Norway	Observer	Norway
14	Lahey Hospital & Medical Center and Harvard Medical School	Observer	United States
15	Fraunhofer Institute for Cell Therapy and Immunology	Observer	Germany
16	University of Antwerp	Observer	Belgium
17	Ben-Gurion University	Observer	Israel
18	Amref International University	Observer	Kenya
19	National Autonomous University of Mexico	Observer	Mexico
20	Ahimsa Fund	Observer	France
21	Erasmus MC University Medical Center	Observer	Netherlands
22	Barcelona Institute for Global Health (ISGlobal)	Observer	Spain
23	University Hospital Münster	Observer	Germany
24	Hahn-Schickard, University of Freiburg	Observer	Germany
25	National Infection Service, Public Health England	Observer	United Kingdom
26	Ain Shams University	Observer	Egypt
27	ND4ID (New Diagnostics for Infectious Diseases)	Observer	Belgium
28	Center for Disease Dynamics, Economics & Policy	Observer	India
29	Indian Institute of Technology	Observer	India
30	London School of Hygiene & Tropical Medicine	Observer	United Kingdom
31	London School of Hygiene & Tropical Medicine	Observer	United Kingdom
32	University of Edinburgh	Observer	United Kingdom
33	Infection Control Africa Network	Observer	South Africa
34	Max von Pettenkofer Institute Munich	Observer	Germany
35	Freie Universität Berlin	Observer	Germany
36	University Hospitals Geneva	Observer	Switzerland
37	University of Toronto	Observer	Canada
38	Centre for Cellular and Molecular Platforms	Observer	India
39	University of Edinburgh	Observer	United Kingdom
40	Institute of Medical Microbiology and Infection Control	Observer	Germany
41	European Public Health Association and Gvm Care and Research	Observer	Italy
42	MSF	Observer	Switzerland